Evercore ISI Group Maintains Outperform on Guardant Health, Raises Price Target to $200

Benzinga Newsdesk www.benzinga.com Positive 93.1%

Neg 0% Neu 0% Pos 93.1%

Evercore ISI Group analyst Vijay Kumar maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $160 to $200.